Nuclear medicine departments may wish to evaluate the feasibility of undertaking education of the hybrid imaging workforce is crucial to the future utilisation of this
CT examinations during periods where access to radiopharmaceuticals is limited important area of clinical practice.
(eg early morning/late afternoon), or utilising the CT component of the hybrid
unit for out-of-hours work to alleviate some of the demands on the radiology
References
department’s main CT unit. This may require some degree of cross pollination of
1. Schillaci O, Danieli R, Manni C, Simonetti G. (2004) Is SPECT/CT with a hybrid
training requirements
26
and the development of appropriate educational curriculum
camera useful to improve scintigraphic imaging interpretation? Nuclear Medicine
Communications, Volume 25, pp 705-710.
within the workplace and at academic institutions. Educational programmes for
2. Department of Health (1999) Ionising Radiation (Medical Exposure) Regulations
nuclear medicine technologists in North America and Australia provide focused
2000, London, Department of Health.
academic and clinical training specifically related to the utilisation of CT within the
3. Bateman TM, Cullom SJ. (2005) Attenuation correction Single Photon Emission
nuclear medicine environment.
Computed Tomography Myocardial Perfusion Imaging, Seminars in Nuclear Medicine,
Volume 35, pp 37-51.
In the USA, working relationships between the Society of Nuclear Medicine 4. Sorenson SA, Phelps ME. (2003) Physics in Nuclear Medicine, 3rd Edition,
Technologists and the American Society for Radiologic Technologists are considered
There is
Philadelphia, Saunders.
to be a good example of a synergistic approach to the training requirements
5. Ficaro EP, Fessler JA, Ackermann RJ. (1995) Simultaneous transmission-emission
between professions. The University of Sydney in Australia also offers a dedicated
a debate
thallium-201 cardiac SPECT: Effect of attenuation correction on myocardial tracer
distribution, Journal of Nuclear Medicine, Volume 36, pp 921.
distance based CT module aimed at nuclear medicine technologists who are
6. Ficaro EP. (2002) Controversies – Should SPET attenuation correction be more widely
involved in using CT within a nuclear medicine environment. In the UK, there
about the employed in routine clinical practice? – For, European Journal of Nuclear Medicine, Vol
is limited scope for the provision of a dedicated hybrid imaging programme. 29, 3, pp 409-411.
However, short courses for technologists related to the safe use of CT, and hybrid
appropriate
7. Prvulovich EM, Lonn AHR, Bomanji JB. (1997) Effect of attenuation correction on
imaging modules of study have emerged from two academic institutes over the
myocardial thallium-201 distribution in patients with a low likelihood of coronary
last couple of years. Currently, it is unclear what CT training requirements are
use of low
artery disease, European Journal of Nuclear Medicine, pp 266-275.
needed officially by a technologist working within the hybrid nuclear medicine
8. Hendel RC, Berman DS, Cullom SJ. (1999) Mulicenter clinical trial to evaluate
the efficacy of correction for photon attenuation and scatter in SPECT myocardial
field, especially if the CT unit has a multislice configuration and the imaging
dose CT
perfusion imaging, Circulation, Volume 99, pp 2742-2749.
parameters are interchangeable. A clear educational strategy is required for
9. Duvernoy CS, Ficaro EP, Karabajakian MZ. (2000) Improved detection of left main
the safe and optimal use of CT within a hybrid nuclear medicine environment,
coronary artery disease with attenuation corrected SPECT, Journal of Nuclear
to minimise patient dose and optimise disease detection, aiding patient Cardiology, Volume 7, pp 639-648.
management. 10. Seo Y, Mari C, Hasegawa B. (2008) Technological development and advances in
SPECT/CT, Seminars in Nuclear Medicine, Volume 38, pp 177-198.
Conclusion
11. Koral KF, Dewaraja Y. (2000) Initial results for hybrid SPECT – conjugate-view tumor
Following the inception of SPECT-CT hybrid technology, there appears to be an
dosimetry in I-131 anti-B1 antibody therapy of previously untreated patients with
lymphoma, Journal of Nuclear Medicine, Volume 41, pp 1579-1586.
evolution in the useful applications associated with this modality. Initial ‘low-
12. Koral KF, Dewaraja Y. (2003) Update on hybrid conjugate view SPECT tumour
end’ systems introduced over a decade ago provided a platform for improved
dosimetry and response in I-131 tositumomab therapy of previously untreated
anatomical localisation and high photon-flux attenuation co-efficient data, lymphoma patients, Journal of Nuclear Medicine, Volume 44, pp 457-464.
potentially improving the sensitivity and specificity of existing imaging techniques. 13. Van der Ploeg I, Renato A, Valdés Olmos B, Kroon R, Emiel J, Rutgers T, Omgo N,
Beyond the existing techniques, SPECT-CT has the potential for mirroring the
(2009) The hidden sentinel node and SPECT/CT in breast cancer patients, European
success of PET-CT in terms of radiotherapy planning, dosimetry calculations and
Journal of Nuclear Medicine and Molecular Imaging, Volume 36, pp 6-11.
multi-imaging approaches, which include coronary artery calcium scoring and
14. Schillaci O, Filippi L, Manni C, Santoni R, (2007) Single-Photon Emission Computed
Tomography / Computed Tomography in Brain Tumours, Seminars in Nuclear
myocardial perfusion imaging.
Medicine, Volume 37, pp 34-47.
15. Krausz Y, Israel O, (2006) SPECT/CT in Endocrinology, Seminars in Nuclear Medicine,
As detector technology also continues to evolve, the overall design and utilisation
Volume 36, pp 267-274.
of future SPECT/CT units may further develop. The use of solid state materials such
16. Schillaci O, (2006) SPECT/CT in lung cancer and malignant lymphoma, Seminars in
as cadmium-zinc-telluride will provide a single detector interface and, potentially, Nuclear Medicine, Volume 36, pp 275-285.
improve the functional count rate and spatial resolution further. The training and 17. Horger M, MD Bares R, (2006) The Role of Single-Photon Emission Computed
48
|
IMAGING & ONCOLOGY
|
2009
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64